Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.Grobbee EJ, Schreuders EH, Hansen BE, Bruno MJ, Lansdorp-Vogelaar I, Spaander MCW, Kuipers EJ. Gastroenterology. 2017 Jul 28. [Epub ahead of print]
BACKGROUND & AIMS:Colorectal cancer (CRC) screening using quantitative fecal immunochemical tests (FITs) is rapidly gaining ground worldwide. FITs are invariably used in a dichotomous manner using pre-specified cut-off values. To optimize FIT-based screening programs, we investigated the association between fecal hemoglobin (fHb) concentrations below the FIT cut-off value and later development of colorectal advanced neoplasia.
METHODS:We analyzed data collected from a population-based study of 9561 average-risk subjects (50-74 yrs old) in the Netherlands who were offered 4 rounds of FIT screening for CRC from November 2006 through December 2014. We analyzed data from 7663 participants screened at least once and found to have a negative FIT result at baseline (below the cut-off value of 10 μg Hb/ g feces). Participants were followed for a median 4.7 yrs (interquartile range, 2.0-6.1 yrs); CRCs diagnosed outside the screening program were identified from the Dutch Comprehensive Cancer Centre database. Hazard ratios for advanced neoplasia were determined using Cox proportional hazard regression analyses. Logistic regression techniques were used to calculate risks of advanced neoplasia after consecutive fHb concentrations below the cut-off value.RESULTS:After 8 years of follow up, participants with baseline concentrations of 8-10 μg fHb/g had a higher cumulative incidence of advanced neoplasia (33%) than participants with 0 μg fHb/g (5%) (P<.001). Multi-variate hazard ratios increased from 1.2 for subjects with concentrations of 0-2 μg fHb/g to 8.2 for subjects with concentrations of 8-10 μg fHb/g (P<.001). Participants with 2 consecutive fHb concentrations of 8 μg Hb/g had a 14-fold increase in risk of advanced neoplasia compared to participants with 2 consecutive fHb concentrations of 0 μg Hb/g (P<.001).
CONCLUSIONS:In a population-based study of average-risk individuals with a FIT result below the cut-off value, we associated baseline concentrations of 8-10 μg fHb/g with an increased risk of advanced neoplasia compared to baseline concentrations of 0 μg fHb/g. Baseline and consecutive fHb concentrations are independent predictors for incident advanced neoplasia. This information might be used in designing personalized strategies for population-based CRC screening and reduce unnecessary repeat tests.

